The prevalence of nonalcoholic fatty liver disease (NAFLD), one of the most common
chronic liver diseases worldwide, has been increasing. In terms of pathological changes …

High prevalence of non-alcoholic fatty liver disease (NAFLD) and very diverse outcomes that
are related to disease form and severity at presentation have made the search for …

Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease and
represent a common finding in highly prevalent metabolic disorders (ie type 2 diabetes …

Nonalcoholic fatty liver disease (NAFLD) ranges from simple steatosis to NAFLD-related
liver cirrhosis and is a main cause of chronic liver diseases. Patients with nonalcoholic …

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
throughout the world. Hepatocellular carcinoma (HCC) and liver cirrhosis can result from …

Non-alcoholic fatty liver disease (NAFLD) is a major public health problem afflicting
approximately one billion individuals worldwide. Liver biopsy is considered the gold …

Background Non‐alcoholic fatty liver disease (NAFLD) encompasses a wide spectrum of
clinical conditions, actually representing an emerging disease of great clinical interest …

Hepatic steatosis is the buildup of lipids within hepatocytes. It is the simplest stage in
nonalcoholic fatty liver disease (NAFLD). It occurs in approximately 30% of the general …

Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver
disease and is a major public health problem worldwide. It is a spectrum that includes …

Nonalcoholic fatty liver disease (NAFLD) is the commonest chronic liver disease and
includes simple steatosis and nonalcoholic steatohepatitis (NASH). Since NASH progresses …